Анестезия у пациентов с сопутствующими заболеваниями центральной нервной системы: обзор литературы

Н.В. Трембач

ФГБОУ ВО «Кубанский государственный медицинский университет» Минздрава России, Краснодар

Для корреспонденции: Трембач Никита Владимирович — канд. мед. наук, ассистент кафедры анестезиологии, реаниматологии и трансфузиологии ФПК и ППС ФГБОУ ВО «КубГМУ» Минздрава России, Краснодар; e-mail: nikitkax@mail.ru

Для цитирования: Трембач Н.В. Анестезия у пациентов с сопутствующими заболеваниями центральной нервной системы: обзор литературы. Вестник интенсивной терапии. 2017;3:19–34.


Хронические врожденные и приобретенные заболевания центральной нервной системы — это гетерогенная группа заболеваний, этиология и патогенез которых достаточно разнообразен, связан с повреждением как головного, так и спинного мозга. К таким заболеваниям относят последствия острого нарушения мозгового кровообращения, внутричерепную гипертензию, болезнь Альцгеймера, болезнь Паркинсона, болезнь Хантингтона, эпилепсию, рассеянный склероз, последствия полиомиелита, боковой амиотрофический склероз, сирингомиелию, последствия травмы спинного мозга. В обзоре представлены подходы к предоперационной оценке и подготовке, выбору метода анестезии и препаратов для анестезии, тактика миоплегии у пациентов с заболеваниями центральной нервной системы.

Ключевые слова: анестезия, сопутствующие заболевания центральной нервной системы

Поступила: 10.06.2017


Литература

  1. Mandal K., Saharan S., Penna O., Fodale V. Anesthesia Issues in Central Nervous System Disorders. Curr. Aging. Sci. 2016; 9(2): 116-143.
  2. Hachenberg , Schneemilch C. Anesthesia in neurologic and psychiatric diseases: is there a ‘best anesthesia’ for certain dis- eases? Curr. Opin. Anaesthesiol. 2014; 27(4): 394-402.
  3. Mashour A., Moore L.E., Lele A.V. Journal of Perioperative Care of Patients at High Risk for Stroke during or after Non-Cardiac, Non-Neurologic Surgery: Consensus Statement from the Society for Neuroscience in Anesthesiology and Critical Care. J. Neurosurgical Anesthesiology 2014; 26(4): 273-285.
  4. Chan W. Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults. J. Neurol. 2017; 264(8): 1622-1633. doi: 10.1007/s00415-017- 8401-7.
  5. Заболотских Н.В., Заболотских И.Б., Юхнов В.А. Способ неинвазивного определения внутричерепного давления. Патент на изобретение № 2185091, зарегистрирован в ГРИ 20.07.2002. [Zabolotskikh V., Zabolotskikh I.B., Yukhnov V.A. Sposob neinvazivnogo opredeleniya vnutricherepnogo davleniya. Patent na izobretenie № 2185091, zaregistrirovan v GRI 20.07.2002. (In Russ)]
  6. Motschmann M., Muller C., Walter S. A reliable procedure for noninvasive determination of intracranial pressure. Ophthalmol. 2000; 97(12): 860–862. doi: 10.1007/s003470070009.
  7. Harder B., Hennerici M.G., Jonas J.B. Ophthalmodynamometry of central retinal vein collapse pressure in idiopathic intracranial hypertension. Klin. Monbl. Augenheilkd. 2007; 224(11): 852–855. doi: 1055/s-2007-963634.
  8. Jonas J.B., Pfeil K., Chatzikonstantinou A. Ophthalmodynamometric measurement of central retinal vein pressure as surrogate of intracranial pressure in idiopathic intracranial hypertension. Graefes Arch. Clin. Exp Ophthalmol. 2008; 246(7): 1059–1060. doi: 1007/s00417-008-0780-0.
  9. Querfurth W., Lieberman P., Arms S. Ophthalmodynamometry for ICP prediction and pilot test on Mt. Everest. BMC Neurol. 2010; 10: 106. doi: 10.1186/1471-2377-10-106.
  10. Talke O., Sharma D., Heyer E.J. et al. Society for Neuroscience in Anesthesiology and Critical Care expert consensus statement: Anesthetic management of endovascular treatment of acute ischemic stroke. J. Neurosurg. Anesthesiol. 2014; 26: 95–108. doi: 10.1097/ANA.0000000000000042.
  11. Aries M.J., Elting J.W., De Keyser J. et al. Cerebral autoregulation in stroke: A review of transcranial Doppler studies. Stroke. 2010; 41: 2697–2704. doi: 1161/STROKEAHA.110.594168.
  12. Blanco M., Nombela , Castellanos M. et al. Statin treatment withdrawal in ischemic stroke: A controlled randomized study. Neurology. 2007; 69: 904–910.
  13. Заболотских И.Б., Синьков С.В., Лебединский К.М., Буланов А.Ю. Анестезиология-реаниматология: клинические рекомендации: под ред. И.Б. Заболотских, Е.М. Шифмана. М.: ГЭОТАР-Медиа, 2016: 315–364. [Zabolotskikh I.B., Sin’kov V., Lebedinsky K.M., Bulanov A.Yu. Anesteziologiya- reanimatologiya: klinicheskie rekomendatsii: eds. I.B. Zabo- lotskikh, E.M. Shifman. Moscow: GEOTAR-Media, 2016: 315-364. (In Russ)]
  14. London J., Hur K., Schwartz G.G. et al. Association of perioperative beta-blockade with mortality and cardiovascular mor- bidity following major noncardiac surgery. JAMA. 2013; 309: 1704–1713. doi: 10.1001/jama.2013.4135.
  15. Fleischmann E., Beckman J.A., Buller C.E. et al. 2009 ACCF/ AHA focused update on perioperative beta blockade. J. Am. Coll. Cardiol. 2009; 54: 2102–2128.
  16. Leslie K., Myles S., Chan M.T. et al. Nitrous oxide and long- term morbidity and mortality in the enigma trial. Anesth. Analg. 2011; 112: 387–393.
  17. Sanders D., Graham C., Lewis S.C. et al. Nitrous oxide expo- sure does not seem to be associated with increased mortality, stroke, and myocardial infarction: A non-randomized subgroup analysis of the general anaesthesia compared with local anaesthesia for carotid surgery (GALA) trial. Br. J. Anaesth. 2012; 109: 361–367.
  18. Leslie K., Myles , Devereaux P.J. et al. Nitrous oxide and serious morbidity and mortality in the POISE tri- al. Anesth. Analg. 2013; 116: 1034–1040. doi: 10.1213/ ANE.0b013e318270014a.
  19. Memtsoudis S.G., Sun X., Chiu L. et al. Perioperative comparative effectiveness of anesthetic technique in orthopedic pa- tients. Anesthesiology. 2013; 118: 1046–1058.
  20. Mortazavi M., Kakli H., Bican O. et al. Perioperative stroke after total joint arthroplasty: Prevalence, predictors, and outcome. J. Bone Joint Surg. Am. 2010; 92: 2095–2101.
  21. Engelhard K. Anaesthetic techniques to prevent perioperative stroke. Opin. Anaesthesiol. 2013; 26: 368–374.
  22. Jacobi J., Bircher N., Krinsley J. et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill Crit. Care Med. 2012; 40: 3251–3276.
  23. Bijker J.B., Persoon S., Peelen L.M. et al. Intraoperative hypotension and perioperative ischemic stroke after general surgery: A nested case-control study. Anesthesiology. 2012; 116: 658–664.
  24. Mashour G.A., Sharifpour M., Freundlich R.E. et al. Perioperative metoprolol and risk of stroke after noncardiac surgery. Anesthesiology. 2013; 119: 1340–1346.
  25. Liu G., Slater N., Perkins A. Epilepsy: Treatment Options. Fam. Physician. 2017; 96(2): 87-96.
  26. Bloor , Nandi R., Thomas M. Antiepileptic drugs and anesthesia. Paediatr. Anaesth. 2017; 27(3): 248-250. doi: 10.1111/ pan.13074.
  27. Bajwa J., Jindal R. Epilepsy and nonepilepsy surgery: Recent advancements in anesthesia management. Anesth. Essays. Res. 2013; 7(1): 10-7. doi: 10.4103/0259-1162.113978.
  28. Maranhao V., Gomes E.A., Carvalho P.E. Epilepsy and Anesthesia. Rev. Bras. Anestesiol. 2011; 61: 232–241.
  29. Kofke A. Anesthetic management of the patient with epilepsy or prior seizures. Curr. Opin. Anaesthesiol. 2010; 23(3): 391- 399.
  30. Thaler A., Siry R., Cai L. et al. Memory Loss, Alzheimer’s Disease and General Anesthesia: A Preoperative Concern. J. Anesth. Clin. Res. 2012; 3(2).
  31. El Haj M., Kapogiannis Time distortions in Alzheimer’s dis- ease: a systematic review and theoretical integration. NPJ Aging Mech. Dis. 2016; 2: 16016.
  32. Scott A., Silbert B.S., Evered L.A. Anesthesia and Alzheimer’s disease: time to wake up! Int. Psychogeriatr. 2013; 25(3): 341- 344.
  33. Berger M., Burke J., Eckenhoff R., Mathew J. Alzheimer’s disease, anesthesia, and surgery: a clinically focused J. Cardiothorac. Vasc. Anesth. 2014; 28(6): 1609-1623.
  34. Sanchez Morillo J., Demartini Ferrari A., Roca de Togores Lopez A. Interaction of donepezil and muscular blockers in Alzheimer’sdisease. Revista espanola de anestesiologia y reanimacion. 2003; 50: 97-100.
  35. Baruah J., Easby J., Kessell G. Effects of acetylcholinesterase inhibitor therapy for Alzheimer’s disease on neuromuscular block. Brit. J. Anaesth. 2008; 100: 420.
  36. Halbritter T. Management of a patient with post-polio J. Am. Acad. Nurse Pract. 2001; 13(12): 555-559.
  37. Schwartz A., Bosch L.M. Anesthetic implications of postpolio syndrome: new concerns for an old disease. AANA J. 2012; 80(5): 356-361.
  38. Higashizawa , Sugiura J., Takasugi Y. Spinal anesthesia in a patient with hemiparesis after poliomyelitis. Masui. 2003; 52(12): 1335-1337.
  39. Lambert A., Giannouli E., Schmidt B.J. Postpolio syndrome and anesthesia. Anesthesiology. 2005; 103(3): 638-644.
  40. Makris A., Piperopoulos A., Karmaniolou I. Multiple sclerosis: basic knowledge and new insights in perioperative manage- ment. Anesth. 2014; 28(2): 267–278.
  41. Luo C., Jian C., Liao et al. The role of microglia in multiple sclerosis. Neuropsychiatr. Dis. Treat. 2017; 13: 1661–1667. doi: 10.2147/NDT.S140634.
  42. Dargahi N., Katsara M., Tselios et al. Multiple Sclerosis: Immunopathology and Treatment Update. Brain Sci. 2017; 7(7): pii: E78. doi: 10.3390/brainsci7070078.
  43. Dorotta R., Schubert A. Multiple sclerosis and anesthetic impli- cations. Curr. Opin. Anaesthesiol. 2002; 15(3): 365–370.
  44. Vercauteren M., Heytens Anaesthetic considerations for pa- tients with a pre-existing neurological deficit: are neuraxial tech- niques safe? Acta Anaesthesiol. Scand. 2007; 51(7): 831–838.
  45. McSwain J.R., Doty J.W., Wilson S.H. Regional anesthesia in patients with pre-existing neurologic Curr. Opin. Anaes- thesiol. 2014; 27(5): 538–543.
  46. Kimura M., Saito S. Anesthesia for patients with neurological diseases. Masui. 2010; 59(9): 1100–1104.
  47. Pu J., Xu L., Yin X., Zhang B. Intracranial hypertension as the primary symptom of gastric signet-ring cell carcinoma: A case report and literature Medicine (Baltimore). 2016; 95(35): e4687. doi: 10.1097/MD.0000000000004687.
  48. Костылев А.Н., Заболотских Н.В. Определение некоторых патофизиологических механизмов развития венозной эн- цефалопатии у больных с шейным остеохондрозом на эта- пах анестезии. Вестник интенсивной терапии. 1999; 5–6: [Kostylev A.N., Zabolotskikh N.V. Opredelenie nekotorykh patofiziologicheskikh mekhanizmov razvitiya venoznoy entsefalopatii u bol’nykh s sheynym osteokhondrozom na etapakh anestezii. Vestnik intensivnoy terapii. 1999; 5–6: 153. (In Russ)]
  49. Pasternak J., Lanier W.R. Diseases Affecting the Brain. In: Stoelting’s Anesthesia and Co-Existing Disease: eds. R.L. Hines, K.E Marschall. 6th ed. 2012: 199–236.
  50. Audibert G., Steinmann G., Charpentier C., Mertes M. Anaesthetic management of the patient with acute intracranial hyper- tension. Ann. Fr. Anesth. Reanim. 2005; 24(5): 492–501.
  51. Zabolotskikh I., Trembach , Gormakova E., Marinochkina L. Comparison of sevoflurane-fentanyl anesthesia and propo- fol-fentanyl total intravenous anesthesia during major abdominal surgery in patients with increased intracranial pressure. Eur. J. Anaesthesiol. 2013; 30(suppl. 51): 114–115.
  52. Заболотских И.Б., Трембач Н.В., Гормакова Е.В. Ди- намика внутримозгового и мозгового перфузионного давления при обширных абдоминальных операциях. Анестезиология и реаниматология. 2013; 3: 21-24. [Zabolotskikh I.B., Trembach N.V., Gormakova E.V. Dinamika vnutrimozgovogo i mozgovogo perfuzionnogo davleniya pri obshirnykh abdominal’nykh operatsiyakh. Anesteziologiya i reanimatologiya. 2013; 3: 21–24. (In Russ)]
  53. Заболотских И.Б., Трембач Н.В. Влияние анестезии на частоту развития делирия после обширных абдоминаль- ных операций у пожилых больных Анестезиология и реаниматология. 2013; 6: 4–6. [Zabolotskikh I.B., Trembach V. Vliyanie anestezii na chastotu razvitiya deliriya posle obshirnykh abdominal’nykh operatsiy u pozhilykh bol’nykh Anesteziologiya i reanimatologiya. 2013; 6: 4–6. (In Russ)]
  54. Burn J.M., Guyer P.B., Langdon L. The spread of solutions injected into the epidural space. Br. J. Anaesth. 1973; 45: 338– 345. doi: 10.1093/bja/45.4.338.
  55. Paul D.L., Wildsmith J.A.W. Extradural pressure following the injection of two volumes of bupivicaine. J. Anaesth. 1989; 6: 368–372. doi: 10.1093/bja/62.4.368.
  56. Usubiaga J.E., Usubiaga L.E., Brea L.M., Goyena R. Effect of saline injections on epidural and subarachnoid space pressures and relation to postspinal anesthesia headache. Analg. 1967; 46: 293–296.
  57. Hilt H., Gramm H.J., Link J. Changes in intracranial pressure associated with extradural anaesthesia. J. Anaesth. 1986; 58: 676–680. doi: 10.1093/bja/58.6.676.
  58. Grocott P., Mutch W.A. Epidural anesthesia and acutely increased intracranial pressure: lumbar epidural space hydrody- namics in a porcine model. Anesthesiology. 1996; 85: 1086– 1091. doi: 10.1097/00000542-199611000-00017.
  59. Hirabayashi , Shimzu R., Matsuda I., Inoue S. Effect of extradural compliance and resistance on spread of extradural analgesia. Br. J. Anaesth. 1990; 65: 508–513. doi: 10.1093/ bja/65.4.508.
  60. Zabolotskikh I., Trembach N. Safety and efficacy of combined epidural/general anesthesia during major abdominal surgery in patients with increased intracranial pressure: a cohort study. BMC 2015; 15: 76. doi: 10.1186/s12871-015-0056- 2.
  61. Заболотских И.Б., Трембач Н.В., Гормакова Е.В., Мариночкина Л.С. Безопасность сочетанной анестезии при обширных абдоминальных операциях у пациентов с внутричерепной гипертензией. Вестник анестезиологии и реаниматологии. 2013; 10(3): 026–032.60. [Zabolotskikh I.B., Trembach N.V., Gormakova V., Marinochkina L.S. Bezopasnost’ sochetannoy anestezii pri obshirnykh abdominal’nykh operatsiyakh u patsientov s vnutricherepnoy gipertenziey Vestnik anesteziologii i reanimatologii. 2013; 10(3): 026–032.60. (In Russ)]
  62. Chen S.H., Sung H., Chang P.J. et al. The management of labour using continuous lumbar epidural analgesia with 0.2 % ropivacaine in a parturient with traumatic brain injury. Eur. J. Anaesthesiol. 2005; 22: 634–635. doi: 10.1017/S0265021505211067.
  63. Holyachi T., Karajagi S., Biradar S.M. Anaesthetic Management of a Geriatric Patient with Parkinson’s Disease, who was Posted for Emergency Laparotomy — A Case Report. J. Clin. Diagn. Res. 2013; 7(1): 148–149.
  64. Wullner U., Standop J., Kaut O. et al. Parkinson’s disease. Perioperative Management and anesthesia. 2012; 61: 97–105.
  65. Mariscal A., Medrano I.H., Cánovas A.A. et al. Sociedad Española de Neurología. Perioperative management of Parkinson’s Neurologia. 2012; 27(1): 46–50.
  66. Akbar U., Kurkchubasche A.G., Friedman J.H. Perioperative management of Parkinson’s disease. Expert Neurother. 2017; 17(3): 301–308. doi: 10.1080/14737175.2017.1241143.
  67. Katus L., Shtilbans A. Perioperative management of patients with Parkinson’s disease. J. Med. 2014; 127(4): 275–280. doi: 10.1016/j.amjmed.2013.11.014.
  68. Pringsheim , Wiltshire K., Day L. et al. The incidence and prevalence of Huntington’s disease: a systematic review and meta-analysis. Mov. Disord. 2012; 27: 1083–1091. doi: 10.1002/ mds.25075.
  69. Phillips , Shannon K.M., Barker R.A. The current clinical management of Huntington’s disease. Mov. Disord. 2008; 23: 1491–1504. doi: 10.1002/mds.21971.
  70. Kivela J.E., Sprung J., Southorn A. et al. Anesthetic management of patients with Huntington disease. Anesth. Analg. 2010; 110(2): 515–523.
  71. Blanloeil , Bigot A., Dixneuf B. General anesthesia and Hun- tington chorea. Cah. Anesthesiol. 1982; 30(8): 1105–1108.
  72. Rodrigo R. Huntington’s chorea: midazolam, a suitable induc- tion agent? Br. J. Anaesth. 1987; 59(3): 388–389.
  73. Giroud M., Fabre J.L., Putelat R. et al. Can metoclopramide reveal Huntington’s disease? 1982; 2(8308): 1153.
  74. Cangemi F.Jr., Miller R.J. Huntington’s disease: review and anesthetic case management. Anesth. Prog. 1998; 45(4): 150– 153.
  75. Rouanet C., Reges D., Rocha E. et al. Traumatic spinal cord injury: current concepts and treatment Arq. Neuropsiqui- atr. 2017; 75(6): 387–393. doi: 10.1590/0004-282X20170048.
  76. Pasternak J.J., Lanier W.R. Spinal Cord Disorders. In: Stoelting’s Anesthesia and Co-Existing Disease: eds. L. Hines, K.E. Marschall. 6th ed. 2012: 239–249.
  77. Eldahan C., Rabchevsky A.G. Autonomic dysreflexia after spinal cord injury: Systemic pathophysiology and methods of management. Auton. Neurosci. 2017; 5: pii: S1566-0702(17)30113- 3. doi: 10.1016/j.autneu.2017.05.002.
  78. Petit J.S., Delahaye J.M., Malinovsky J.M. Perioperative management of traumatic spinal cord injured patients after the acute phase. Ann. Anesth. Reanim. 2008; 27(5): 416–425. doi: 10.1016/j.annfar.2008.03.005.
  79. Liu N., Zhou M., Biering-Sørensen , Krassioukov A.V. Iatrogenic urological triggers of autonomic dysreflexia: a system- atic review. Spinal. Cord. 2015; 53(7): 500–509. doi: 10.1038/ sc.2015.39.
  80. Blegvad C., Grotenhuis J.A., Juhler M. Syringomyelia: a practical, clinical concept for classification. Acta Neurochir (Wien). 2014; 156(11): 2127–2138. doi: 1007/s00701-014-2229-z.
  81. Hönemann C., Moormann S., Hagemann O., Doll D. Spinal anesthesia for cesarean delivery in a patient with syringomyelia. Int. J. Gynaecol. Obstet. 2014; 125(2): 172–174.
  82. Murayama K., Mamiya K., Nozaki K. et al. Cesarean section in a patient with syringomyelia. Can. J. Anaesth. 2001; 48(5): 474–477.
  83. Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017; 377(2): 162–172. doi: 10.1056/NEJM- ra1603471.
  84. Thampi S.M., David D., Chandy T., Nandhakumar A. Response to Comments: Anaesthetic management of a patient with amyotrophic lateral sclerosis for transurethral resection of bladder tumour. Indian J. Anaesth. 2013; 57(6): 636–637.